Self Assessment of Buccodental Toxicity - Comparison of Patients With Metastatic Renal-cell Carcinoma (RCC) Treated With Sunitinib to Patients Treated With Chemotherapy

被引：0
|
作者：
Gilabert, M. [1 ]
Provansal, M. [1 ]
Cappiello, M. [1 ]
Walz, J. [1 ]
Brunelle, S. [1 ]
Salem, N. [1 ]
Gravis, G. [1 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72060-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S518 / S518
页数：1
相关论文
共 50 条
  • [21] Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus
    Conteduca, Vincenza
    Santoni, Matteo
    Medri, Matelda
    Scarpi, Emanuela
    Burattini, Luciano
    Lolli, Cristian
    Rossi, Lorena
    Savini, Agnese
    Berardi, Rossana
    Stanganelli, Ignazio
    Cascinu, Stefano
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2016, 14 (05) : 426 - 431
  • [22] PROGNOSTIC FACTORS AND SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA TREATED WITH CHEMOTHERAPY OR INTERFERON-ALPHA
    FOSSA, SD
    KRAMAR, A
    DROZ, JP
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) : 1310 - 1314
  • [23] Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-
    Tsimafeyeu, Ilya
    Zart, Janie S.
    Chung, Bin
    BJU INTERNATIONAL, 2013, 112 (01) : 32 - 38
  • [24] Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib
    Beuselinck, Benoit
    Vano, Yann-Alexandre
    Oudard, Stephane
    Wolter, Pascal
    De Smet, Robert
    Depoorter, Lore
    Teghom, Corine
    Karadimou, Alexandra
    Zucman-Rossi, Jessica
    Debruyne, Philip R.
    Van Poppel, Hendrik
    Joniau, Steven
    Lerut, Evelyne
    Strijbos, Michiel
    Dumez, Herlinde
    Paridaens, Robert
    Van Calster, Ben
    Schoffski, Patrick
    BJU INTERNATIONAL, 2014, 114 (01) : 81 - 89
  • [25] Influence of risk factors for renal cell carcinoma (RCC) on outcome of patients (pts) with metastatic disease (mRCC) treated with sunitinib (Su)
    Berger, Raanan
    Keizman, Daniel
    Ish-Shalom, Maya
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Pili, Roberto
    Boursi, Ben
    Maimon, Natalie
    Gottfried, Maya
    Hayat, Henry
    Peer, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Newly onset hyperlipidemia in metastatic renal cell carcinoma patients treated with sunitinib.
    Baldazzi, Valentina
    Tassi, Renato
    Lapini, Alberto
    Carini, Marco
    Mazzanti, Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [27] ESTIMATED GFR AS A BIOMARKER OF EFFICACY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB
    Kato, Tomoyuki
    Bilim, Vladimir
    Nakayama, Shoko
    Narisawa, Takafumi
    Yamagishi, Atsushi
    Sakurai, Toshihiko
    Nishida, Hayato
    Naito, Sei
    Kawazoe, Hisashi
    Ichiyanagi, Osamu
    Nagaoka, Akira
    Tomita, Yoshihiko
    JOURNAL OF UROLOGY, 2012, 187 (04): : E810 - E810
  • [28] Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma (mRCC) treated with sunitinib?
    Keizman, Daniel
    Ish-Shalom, Maya
    Maimon, Natalie
    Gottfried, Maya
    Pili, Roberto
    Hammers, Hans J.
    Eisenberger, Mario A.
    Sinibaldi, Victoria J.
    Boursi, Ben
    Weitzen, Rony
    Hayat, Henry
    Peer, Avivit
    Neumann, Avivit
    Kovel, Svetlana
    Sella, Avishay
    Mermershtain, Wilmosh
    Roubinov, Keren
    Carducci, Michael Anthony
    Berger, Raanan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [29] The Impact of Tumor Burden Characteristics in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
    Basappa, Naveen S.
    Elson, Paul
    Golshayan, Ali-Reza
    Wood, Laura
    Garcia, Jorge A.
    Dreicer, Robert
    Rini, Brian I.
    CANCER, 2011, 117 (06) : 1183 - 1189
  • [30] Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
    Motzer, R. J.
    Escudier, B.
    Bukowski, R.
    Rini, B. I.
    Hutson, T. E.
    Barrios, C. H.
    Lin, X.
    Fly, K.
    Matczak, E.
    Gore, M. E.
    BRITISH JOURNAL OF CANCER, 2013, 108 (12) : 2470 - 2477
12345